A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder

Phytotherapy Research

Volumn 21, Issue 9, 2007, Pages 847-851

  Koetter, U ^a   Schrader, E ^b   Kaufeler R ^a   Brattström, Axel ^a  

^a Max Zeller Sohne AG   (Switzerland)

^b Praxis Clinical Drug Research   (Germany)

Author keywords

Sleep improvement; Valerian hops extract

Indexed keywords

HUMULUS LUPULUS EXTRACT; METHANOL; PLACEBO; UNCLASSIFIED DRUG; VALERIAN; ZE 91019; ZE 911;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SYNTHESIS; FEMALE; HOME MONITORING; HUMAN; HUMULUS LUPULUS; INSOMNIA; MALE; MONOTHERAPY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SLEEP DISORDER; SLEEP PARAMETERS; SLEEP TIME; TREATMENT DURATION; TREATMENT OUTCOME; WAKEFULNESS;

ADMINISTRATION, ORAL; ADULT; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HUMULUS; HYPNOTICS AND SEDATIVES; MALE; PHYTOTHERAPY; PLANT EXTRACTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME; VALERIAN;

HUMULUS; VALERIANA;

EID: 34548601656     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2167     Document Type: Article

References (27)

1. Abourashed EA, Koetter U, Brattström A. 2004. In vitro binding experiments with valerian, hops and their fixed combination extract (Ze 91019) to selected central nervous receptors. Phytomedicine 11: 633-638.
2. Anderson GD, Elmer GW, Kantor ED, Templeton IE, Vitiello MV. 2005. Pharmacokinetics of valerenic acid after administration of valerian in healthy subjects. Phytother Res 19: 801-803.
3. Baburin I, Khom S, Hering S, Koetter U, Brattström A. 2006. The effect of valerian extracts on GABA (A)-receptors. In 18th Congress ESRS, Innsbruck (Austria), September 12-16. Journal of Sleep Research 15(Suppl. 1): 143.
4. Butterweck V, Brattstroem A, Grundmann O, Koetter U. 2007. Hypothermic effects of hops are antagonized with the competitive melatonin receptor antagonist luzindole. J Pharmacy Pharmacol 59: 549-552.
5. Dimpfel W, Brattström A, Koetter U. 2006. Central action of a fixed valerian-hops extract combination (Ze 91019) in freely moving rats. Eur J Med Res 11: 496-500.
6. Dietz BM, Mahady GB, Pauli GF, Famsworth NR. 2005. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res Mol Brain Res. 138: 191-7.
7. Ehlert I, Danker-Hopfe H, Höller L, v. Rickenbach P, Baumgart-Schmitt R, Hermann WM. 1998. A comparison between EEG-recording and scoring by QUISI version 1.0 and standard PSG with visual scoring. Somnologie 2: 104-116.
8. Finelli LA, Achermann P, Borbely AA. 2001. Individual fingerprints in human sleep EEG. Neuropsychopharmacology 25: S57-S62.
9. Finelli LA, Baumann H, Borbely AA, Achermann A. 2000. Dual electroencephalogram markers of human sleep homeostase: correlation between theta activity in waking and slow-wave activity in sleep. Neuroscience 101: 523-529.
10. Füssel A, Wolf A, Brattström A 2000. Effect of a fixed valerian hop extract combination (Ze 91019) on sleep polygraphia in patients with non-organic insomnia: a pilot study. Eur J Med Res 5: 385-390.
11. Garges HP, Varia I, Doraiswamy PM. 1998. Cardiac complications and delirium associated with valerian root withdrawal. JAMA 280: 1566-1567.
12. Hobson JA, Pace-Schott EF. 2002. The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nature Rev/Neurosci 3: 679-693.
13. Holbrook AM, Crowther R, Lotter A, Cheng C, King. 2000. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 162: 225-233.
14. Mueller CE, Schuhmacher B, Brattström A, Abourashed EA, Kotter U. 2002. Interaction of valerian and a fixed valerian hops extract combination with adenosine receptors Life Sci 71: 1939-1949.
15. Navarrete A, Avula B, Choi YW, Khan IA. 2006. Chemical fingerprinting of Valeriana species: simultaneous determination of valerenic acid, flavonoids, and phenylpropanoids using liquid chromatography with ultraviolet detection. J AOAC Int 89: 8-15.
16. Porkka-Heiskanen T, Alanko L, Kalinchuk A, Stenberg D. 2002. Adenosine and sleep. Sleep Med Rev 6: 321-332.
17. Schellenberg R, Sauer S, Abourashed EA, Koetter U, Brattström A. 2004. The fixed combination of valerian and hops (Ze 91019) acts via central adenosine receptors. Planta Med 70: 594-597.
18. Schiller KH. 2002. Wirkungen von Zubereitungen aus Humulus lupulus L. in pharmakologischen Modellen. Doctoral Thesis, University Münster.
19. A-receptors. Phytother Res. (in press).
20. Upton R. 1999. Valerian Root: Analytical, Quality Control, and Therapeutic Monograph. Santa Cruz, CA: American Herbal Pharmacopoeia.
21. Vignola A, Lamoureux C, Bastien CH, Morin C. 2000. Effects of chronic insomnia and use of benzodiazepines on daytime performance in older adults. Psychol Sci 55B: P54-P62.
22. Vissiennon Z, Sichardt K, Koetter U, Brattström A, Nieber K. 2006. Valerian extract Ze 911 inhibits postsynaptic potentials by activation of adenosine A1 receptors in rat cortical neurons. Planta Med 72: 579-583.
23. Vonderheid-Guth B, Todorova A, Brattström A, Dimpfel W. 2000. Pharmacodynamic effect of a valerian hop extract combination (Ze 91019) of the quantitative-topographical EEG in healthy volunteers. Eur J Med Res 5: 139-144.
24. Wiener SW, Hoffman RS, Nelson LS. 2003. Withdrawal symptoms after valerian cessation. J Toxicol Clin Toxicol 41: 721.
25. Wyatt JK, Dijk DJ, Ritz-DeCecco A, Ronda KM, Czeisler CA. 2006. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian dependent. Sleep 29: 609-618.
26. Yuan CS, Mehendale S, Xiao Y, Aung HH, Xie JT, Ang-Lee MK. 2004. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth Analg 98: 353-358.
27. Zanoli P, Rivasi M, Zavatti M, Brusiani F, Baraldi M. 2005. New insight in the neuropharmacological activity of Humulus lupulus L. J Ethnopharmacol 102: 102-106.